Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials-Reference-Cited by-同舟云学术

Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials

Published:2019-12 Issue: Volume:123 Page:101-111
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ronellenfitsch Ulrich^ORCID,Jensen Katrin,Seide Svenja,Kieser Meinhard,Schwarzbach Matthias,Slanger Tracy E.,Burmeister Bryan,Kelsen David,Niedzwiecki Donna,Piessen Guillaume,Schuhmacher Christoph,Urba Susan,van de Velde Cornelis,Ychou Marc,Hofheinz Ralf,Lorenzen Sylvie

Funder

Federal Ministry of Education and Research

University of Heidelberg

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Epidemiology, diagnosis, and management of esophageal adenocarcinoma;Rubenstein;Gastroenterology,2015

2. Stomach cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study;Jim;Cancer,2017

3. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data;Ronellenfitsch;Eur J Cancer,2013

4. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

5. Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review;Schirren;Ther Adv Med Oncol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Time-to-event Surrogate Endpoint Endpoint ─Meta-analytic Approach─;Japanese Journal of Biometrics;2024-07-30

2. A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11

3. Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer: A Systematic Review and Meta-analysis;Annals of Surgical Oncology;2023-07-03

4. Event-Free Survival as a Surrogate for Overall Survival in Gastric and Gastroesophageal Junction Adenocarcinoma: A Meta-analysis in the Neoadjuvant ± Adjuvant Setting;Clinical Cancer Research;2023-01-18

5. Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis;European Journal of Cancer;2022-07